Tokyo Tape
Sign in
← Gakken Holdings

Half-year report · Q2

9470.TEDINET S100VPZD
Period2024-10-01 → 2025-03-31
Filed2025-05-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥98.8bn2024-10-01 → 2025-03-31Cons.Net sales
Revenue¥185.6bn2023-10-01 → 2024-09-30Cons.Net sales (5-year summary)
Revenue¥93.5bn2023-10-01 → 2024-03-31Cons.Net sales
Operating income¥4.5bn2024-10-01 → 2025-03-31Cons.Operating income
Operating income¥5.1bn2023-10-01 → 2024-03-31Cons.Operating income
Ordinary income¥4.2bn2024-10-01 → 2025-03-31Cons.Ordinary income
Ordinary income¥6.9bn2023-10-01 → 2024-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥5.2bn2023-10-01 → 2024-03-31Cons.Ordinary income
Profit before tax¥4.4bn2024-10-01 → 2025-03-31Cons.Income before income taxes
Profit before tax¥3.8bn2023-10-01 → 2024-03-31Cons.Income before income taxes
Net income (owners)¥2.4bn2024-10-01 → 2025-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.3bn2023-10-01 → 2024-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.8bn2023-10-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income¥2.5bn2024-10-01 → 2025-03-31Cons.Profit loss
Net income¥1.9bn2023-10-01 → 2024-03-31Cons.Profit loss
Total assets¥141.9bnat 2025-03-31Cons.Assets
Total assets¥130.7bnat 2024-09-30Cons.Assets
Total assets¥139.4bnat 2024-03-31Cons.Total assets (5-year summary)
Total liabilities¥85.0bnat 2025-03-31Cons.Liabilities
Total liabilities¥77.1bnat 2024-09-30Cons.Liabilities
Net assets / equity¥56.9bnat 2025-03-31Cons.Net assets
Net assets / equity¥53.7bnat 2024-09-30Cons.Net assets
Net assets / equity¥54.7bnat 2024-03-31Cons.Net assets (5-year summary)
Cash and deposits¥24.4bnat 2025-03-31Cons.Cash and deposits
Cash and deposits¥20.4bnat 2024-09-30Cons.Cash and deposits
Cash & equivalents¥22.7bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥18.8bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥22.0bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥19.1bnat 2023-09-30dCons.Cash and cash equivalents
Operating cash flow¥1.2bn2024-10-01 → 2025-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥7.2bn2023-10-01 → 2024-09-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.6bn2023-10-01 → 2024-03-31Cons.Net cash provided by used in operating activities
Investing cash flow¥2.8bn2024-10-01 → 2025-03-31Cons.Net cash provided by used in investment activities
Investing cash flow¥1.8bn2023-10-01 → 2024-09-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥3.9bn2023-10-01 → 2024-03-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥166m2024-10-01 → 2025-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥9.4bn2023-10-01 → 2024-09-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥2.5bn2023-10-01 → 2024-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥58.062024-10-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥52.992023-10-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥41.192023-10-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥57.682024-10-01 → 2025-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥52.62023-10-01 → 2024-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥40.872023-10-01 → 2024-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio36.7%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.4%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio37.5%at 2024-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-10-01 → 2025-03-31¥6.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-10-01 → 2025-03-31¥2.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-10-01 → 2025-03-31¥3.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-10-01 → 2025-03-31¥253m
Reconciling Itemsreconcilingrevenue2024-10-01 → 2025-03-31−¥4.1bn
Reconciling Itemsreconcilingrevenue intersegment2024-10-01 → 2025-03-31−¥4.1bn
Reconciling Itemsreconcilingsegment profit2024-10-01 → 2025-03-31−¥1.1bn
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue2024-10-01 → 2025-03-31¥49.8bn
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue external2024-10-01 → 2025-03-31¥49.6bn
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue intersegment2024-10-01 → 2025-03-31¥139m
jpcrp040300-q2r_E00707-000Educationreportable segmentsegment profit2024-10-01 → 2025-03-31¥4.1bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue2024-10-01 → 2025-03-31¥46.4bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue external2024-10-01 → 2025-03-31¥46.3bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue intersegment2024-10-01 → 2025-03-31¥45m
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentsegment profit2024-10-01 → 2025-03-31¥1.3bn
—segment totalrevenue2024-10-01 → 2025-03-31¥96.2bn
—segment totalrevenue external2024-10-01 → 2025-03-31¥96.0bn
—segment totalrevenue intersegment2024-10-01 → 2025-03-31¥184m
—segment totalsegment profit2024-10-01 → 2025-03-31¥5.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-10-01 → 2025-03-31¥102.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-10-01 → 2025-03-31¥98.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-10-01 → 2025-03-31¥4.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-10-01 → 2025-03-31¥5.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-10-01 → 2024-03-31¥7.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-10-01 → 2024-03-31¥3.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-10-01 → 2024-03-31¥4.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-10-01 → 2024-03-31¥282m
Reconciling Itemsreconcilingrevenue2023-10-01 → 2024-03-31−¥4.3bn
Reconciling Itemsreconcilingrevenue intersegment2023-10-01 → 2024-03-31−¥4.3bn
Reconciling Itemsreconcilingsegment profit2023-10-01 → 2024-03-31−¥923m
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue2023-10-01 → 2024-03-31¥48.3bn
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue external2023-10-01 → 2024-03-31¥48.2bn
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue intersegment2023-10-01 → 2024-03-31¥126m
jpcrp040300-q2r_E00707-000Educationreportable segmentsegment profit2023-10-01 → 2024-03-31¥3.7bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue2023-10-01 → 2024-03-31¥42.2bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue external2023-10-01 → 2024-03-31¥42.1bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue intersegment2023-10-01 → 2024-03-31¥27m
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentsegment profit2023-10-01 → 2024-03-31¥2.1bn
—segment totalrevenue2023-10-01 → 2024-03-31¥90.5bn
—segment totalrevenue external2023-10-01 → 2024-03-31¥90.3bn
—segment totalrevenue intersegment2023-10-01 → 2024-03-31¥153m
—segment totalsegment profit2023-10-01 → 2024-03-31¥5.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-10-01 → 2024-03-31¥97.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-10-01 → 2024-03-31¥93.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-10-01 → 2024-03-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-10-01 → 2024-03-31¥6.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 547
ItemContextValueUnit
Current liabilitiesPrior1YearInstant43187000000JPY
Current liabilitiesCurrentQuarterInstant48169000000JPY
Bonds payablePrior1YearInstant－JPY
Bonds payableCurrentQuarterInstant7000000000JPY
Long term loans payablePrior1YearInstant21644000000JPY
Long term loans payableCurrentQuarterInstant17655000000JPY
Net defined benefit liabilityPrior1YearInstant5130000000JPY
Net defined benefit liabilityCurrentQuarterInstant5140000000JPY
Other nclPrior1YearInstant7099000000JPY
Other nclCurrentQuarterInstant7058000000JPY
Noncurrent liabilitiesPrior1YearInstant33873000000JPY
Noncurrent liabilitiesCurrentQuarterInstant36854000000JPY
LiabilitiesPrior1YearInstant77061000000JPY
LiabilitiesCurrentQuarterInstant85023000000JPY
Capital stockPrior1YearInstant19817000000JPY
Capital stockCurrentQuarterInstant19817000000JPY
Capital surplusPrior1YearInstant12102000000JPY
Capital surplusCurrentQuarterInstant11354000000JPY
Retained earningsPrior1YearInstant18615000000JPY
Retained earningsCurrentQuarterInstant20512000000JPY
Treasury stockPrior1YearInstant-2187000000JPY
Treasury stockCurrentQuarterInstant-3029000000JPY
Shareholders equityPrior1YearInstant48348000000JPY
Shareholders equityCurrentQuarterInstant48655000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant1624000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant2030000000JPY
Deferred gains or losses on hedgesPrior1YearInstant-0JPY
Deferred gains or losses on hedgesCurrentQuarterInstant1000000JPY
Foreign currency translation adjustmentPrior1YearInstant385000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant351000000JPY
Remeasurements of defined benefit plansPrior1YearInstant1115000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant1036000000JPY
Valuation and translation adjustmentsPrior1YearInstant3125000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant3419000000JPY
Subscription rights to sharesPrior1YearInstant199000000JPY
Subscription rights to sharesCurrentQuarterInstant168000000JPY
Non controlling interestsPrior1YearInstant1980000000JPY
Non controlling interestsCurrentQuarterInstant4616000000JPY
Net assetsPrior1YearInstant53653000000JPY
Net assetsCurrentQuarterInstant56858000000JPY
Liabilities and net assetsPrior1YearInstant130714000000JPY
Liabilities and net assetsCurrentQuarterInstant141882000000JPY
Net salesPrior1YTDDuration93505000000JPY
Net salesCurrentYTDDuration98841000000JPY
Cost of salesPrior1YTDDuration67011000000JPY
Cost of salesCurrentYTDDuration71850000000JPY
Gross profitPrior1YTDDuration26494000000JPY
Gross profitCurrentYTDDuration26991000000JPY
Selling general and administrative expensesPrior1YTDDuration21353000000JPY
Selling general and administrative expensesCurrentYTDDuration22449000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-09-30pass
balance sheet identityconsolidated 2025-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-10-01/2025-03-31pass
statement vs summary · operating cash flowconsolidated 2023-10-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2024-10-01/2025-03-31pass
statement vs summary · revenueconsolidated 2023-10-01/2024-03-31pass
statement vs summary · revenueconsolidated 2024-10-01/2025-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass